Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosis

Abstract

BackgroundOlfactory threshold (OT) is a marker of short-term inflammatory activity in multiple sclerosis (MS). ObjectiveTo investigate whether OT predicts long-term MS clinical disease course. MethodsThis was a 6-year prospective longitudinal study on MS patients at the MS clinic Innsbruck. Clinical visits assessing the occurrence of relapses, Expanded Disability Status Scale (EDSS) scores, and disease-modifying treatment (DMT), were conducted biannually. OT testing was performed at baseline (BL), year 1 (Y1), year 2 (Y2) and year 6 (Y6), using the threshold subscore of the “Sniffin’ Sticks” test. Cognitive function was assessed by the Symbol Digit Modalities Test. ResultsOf 139 MS patients, 92 were eligible for Y6 follow-up. 68% experienced relapses, 53% EDSS worsening, 29% progression independent of relapse activity (PIRA) and 41% cognitive deterioration. OT scores were lower at BL, Y1 and Y2 in patients requiring DMT escalation. In multivariable analysis, higher OT scores at BL, Y1, Y2 and Y6 were associated with lower risk of relapse (hazard ratio, HR: 0.65–0.92) and EDSS worsening (HR: 0.86–0.89), while no associations were found for PIRA and cognitive deterioration. ConclusionsOT is a potential surrogate marker for long-term inflammatory disease activity and DMT failure in MS.